Topical drug delivery to the eye: dorzolamide.

Topical drug delivery to the eye: dorzolamide.

Item
http://www.wikidata.org/entity/Q37978007
Medical Management of Glaucoma in the 21st Century from a Canadian PerspectiveDevelopment of ocular drug delivery systems using molecularly imprinted soft contact lenses.Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: in-vitroand in-vivo Evaluation in Rabbits.Dorzolamide Loaded Niosomal Vesicles: Comparison of Passive and Remote Loading Methods.Principles of pharmacology in the eye.An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring.Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures.Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post designInsights into gold nanoparticles as a mucoadhesive system
P2860

Topical drug delivery to the eye: dorzolamide.

Item
http://www.wikidata.org/entity/Q37978007
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Topical drug delivery to the eye: dorzolamide.
@en
Topical drug delivery to the eye: dorzolamide.
@nl
type
label
Topical drug delivery to the eye: dorzolamide.
@en
Topical drug delivery to the eye: dorzolamide.
@nl
prefLabel
Topical drug delivery to the eye: dorzolamide.
@en
Topical drug delivery to the eye: dorzolamide.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Topical drug delivery to the eye: dorzolamide.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1755-3768.2011.02299.X
P433
P478
P50
P577
P5875
P698
P921